|
Originally published In Press as doi:10.1074/jbc.M206928200 on July 18, 2002
J. Biol. Chem., Vol. 277, Issue 38, 34743-34748, September 20, 2002
Cysteine Activation Is an Inherent in Vitro Property
of Prolyl-tRNA Synthetases*
Ivan
Ahel ,
Constantinos
Stathopoulos ,
Alexandre
Ambrogelly ,
Anselm
Sauerwald ,
Helen
Toogood ,
Thomas
Hartsch§¶, and
Dieter
Söll ¶
From the Departments of Molecular Biophysics and
Biochemistry and ¶ Chemistry, Yale University, New Haven,
Connecticut 06520-8114 and the § Institut für
Mikrobiologie und Genetik der Universität Göttingen,
D-37077 Göttingen, Germany
Received for publication, July 11, 2002, and in revised form, July 16, 2002
 |
ABSTRACT |
Aminoacyl-tRNA synthetases are well known for
their remarkable precision in substrate selection during aminoacyl-tRNA
formation. Some synthetases enhance the accuracy of this process by
editing mechanisms that lead to hydrolysis of incorrectly activated
and/or charged amino acids. Prolyl-tRNA synthetases (ProRSs) can be
divided into two structurally divergent groups, archaeal-type and
bacterial-type enzymes. A striking difference between these groups is
the presence of an insertion domain (~180 amino acids) in the
bacterial-type ProRS. Because the archaeal-type ProRS enzymes have been
shown to recognize cysteine, we tested selected ProRSs from all three domains of life to determine whether cysteine activation is a general
property of ProRS. Here we show that cysteine is activated by
recombinant ProRS enzymes from the archaea Methanocaldococcus jannaschii and Methanothermobacter
thermautotrophicus, from the eukaryote Saccharomyces
cerevisiae, and from the bacteria Aquifex aeolicus,
Borrelia burgdorferi, Clostridium sticklandii, Cytophaga hutchinsonii, Deinococcus radiodurans, Escherichia coli,
Magnetospirillum magnetotacticum, Novosphingobium aromaticivorans,
Rhodopseudomonas palustris, and Thermus thermophilus.
This non-cognate amino acid was efficiently acylated in
vitro onto tRNAPro, and the misacylated
Cys-tRNAPro was not edited by ProRS. Therefore, ProRS
exhibits a natural level of mischarging that is to date unequalled
among the aminoacyl-tRNA synthetases.
 |
INTRODUCTION |
Aminoacyl-tRNA synthetases
(AARSs)1 ensure accuracy in
the translation of the genetic code by precisely selecting and
attaching their cognate amino acids to the corresponding tRNA species
(1). This is accomplished in a two-step process of amino acid
activation and aminoacyl-tRNA formation. First, the enzyme-bound
aminoacyl-adenylate is formed in the presence of ATP. The activated
amino acid is subsequently transferred to the 3' terminus of the
cognate tRNA (1). Although accurate amino acid recognition by AARSs is
an efficient process, some misactivation or mischarging of non-cognate amino acids has been observed. The incorrect products are usually hydrolyzed during pre-transfer and/or post-transfer editing activities (2). A well described editing model is the "double-sieve" mechanism (3, 4). It suggests that some aminoacyl-tRNA synthetases choose their
cognate amino acids primarily by size and then by specific chemical
features. The active site for aminoacylation acts as the "coarse"
sieve, activating at a significant rate only those amino acids that are
the same size as or smaller than the desired one. The second sieve, the
"fine sieve," is the editing site where the products of those amino
acids that are smaller than the correct one are hydrolyzed. Editing
activities have been demonstrated for many synthetases (5-7), most
recently also for prolyl-tRNA synthetase (ProRS) (8).
ProRS is responsible for the formation of prolyl-tRNA. Progress
in genome analysis has made available a large number of ProRS sequences. Their alignments and phylogenetic examination revealed the
existence of two quite diverged groups (Fig. 1), archaeal-type and
bacterial-type ProRS enzymes (9-12). Bacterial-type ProRS, found in
bacteria and mitochondria, is usually larger than the archaeal-type
enzyme because of an insertion domain of ~180 amino acids (Table I).
However, ProRSs from Rhodopseudomonas palustris, Caulobacter crescentus, Rickettsia prowazekii,
and a few other representatives of -proteobacteria lack this
insertion domain, yet they are bacterial-type enzymes based on
phylogenetic analyses. In contrast, the archaeal-type ProRS lacks the
insertion sequence but contains a conserved C-terminal extension of
~100 amino acids including a totally conserved terminal tyrosine
(Fig. 1). In addition to its occurrence in archaea and eukarya, the
archaeal-type ProRS is also found in the bacterial domain in the
Thermus-Deinococcus group, the
Cytophaga-Flexibacter-Bacteroides group,
Borrelia, some Clostridium species, and some
-proteobacteria.
Although the ProRS enzymes from Escherichia coli and
Thermus aquaticus have been purified and partially
characterized many years ago, all 20 canonical amino acids had not been
tested for their ability to be substrates (13, 14). Thus, it was
surprising that archaeal ProRS enzymes were shown to be capable of
activating cysteine in addition to the cognate proline (15, 16). This appeared to be a desirable property as the methanogenic archaea Methanocaldococcus jannaschii and Methanothermobacter
thermautotrophicus lack a canonical cysteinyl-tRNA synthetase in
their genomes (17, 18), and Cys-tRNACys formation was
reported to be carried out by a dual specificity ProRS (15, 16).
Furthermore, the binding sites for proline and cysteine greatly overlap
in M. jannaschii ProRS (19). Recently, however, cysteine
activation was also detected for human (20), Giardia lamblia
(21), Thermus thermophilus (22), and even the bacterial-type
E. coli ProRS (20, 23). This immediately raised the question
whether cysteine activation is an inherent in vitro property
of all ProRS enzymes. To provide an answer, we examined ProRS enzymes
from a number of representative organisms for amino acid activation and
tRNA charging with cysteine.
 |
EXPERIMENTAL PROCEDURES |
General--
Proline and cysteine were purchased from Sigma and
were analyzed for purity by the Keck Foundation Research Biotechnology Resource Laboratory at Yale University. [35S]Cysteine
(1075 Ci/mmol) and [32P]pyrophosphate (PPi)
(15 Ci/mmol) were from PerkinElmer Life Sciences, and
[3H]proline (104 Ci/mmol), [14C]proline
(248 mCi/mmol), and [3H]alanine (52 Ci/mmol) were from
Amersham Biosciences. Nickel-nitrilotriacetic acid matrix was from
Qiagen. GF/C glass microfiber filters were from Whatman. Nitrocellulose
filters (0.45 µm) were from Schleicher & Schuell. Inorganic
pyrophosphatase (0.2 units/µl) was from Roche Molecular Biochemicals.
The TOPO-TA cloning kit was from Invitrogen. Epicurian coli©
BL21-CodonPlusTM competent cells were purchased from
Stratagene. Bulk mature E. coli tRNA was purchased from
Sigma, and bulk mature yeast tRNA was from Roche Molecular Biochemicals.
Preparation of Native tRNAs--
Unfractionated mature tRNA from
M. jannaschii was prepared as described previously
(24). EF1A-purified E. coli tRNACys
and T. thermophilus tRNACys were prepared as
described (see Ref. 45).
Partial separation of E. coli tRNAs was performed at 4 °C
by chromatography on benzoylated DEAE-cellulose at pH 7.0 in the presence of Mg2+ as described previously (25).
tRNA (40 mg) was adsorbed to a benzoylated DEAE-cellulose column
(2.5 × 8 cm) in 50 mM MOPS-HCl, pH 7.0, containing 10 mM MgCl2. Elution was performed with a linear gradient of NaCl (0-1.0 M, 400 ml of total volume) at a
flow rate of 1 ml/min maintained with 5-ml fractions collected. The
fractions were assayed for presence of tRNAPro and
tRNACys by charging with E. coli ProRS and
cysteinyl-tRNA synthetase. A fraction enriched in tRNAPro
(~150 pmol of proline/A260) and devoid of
tRNACys was used in this study.
Preparation of tRNA Genes and Transcripts--
E.
coli (CGG) and M. jannaschii (UGG)
tRNAPro genes were synthesized as described previously (15,
19) and then transcribed from NsiI or
BstNI-linearized plasmids using T7 polymerase. E. coli transcript was prepared as a ribozyme construct, because the
first base is cytosine, which is highly unfavorable for T7 polymerase
(26). Digested template DNA was extracted with phenol and chloroform
and precipitated with ethanol. The transcription reaction was incubated
at 37 °C for 3 h and included 40 mM Tris-HCl, pH
8.1, 22 mM MgCl2, 2 mM spermidine,
10 mM dithiothreitol, 4 mM of each NTP (Sigma),
10 mM GMP (Sigma), 0.05% Triton X-100, 10 mg/ml yeast
inorganic pyrophosphatase, 0.1 mg/ml digested template, and 50 µg/ml
T7 polymerase. Reactions were stopped by phenol and chloroform
extraction, precipitated with ethanol, and resuspended in gel loading
buffer (8 M urea, 20% sucrose, 0.1% bromphenol blue,
0.1% xylene cyanol). For ribozyme constructs before the phenol
extraction, reaction mixtures were diluted five times and incubated for
1 h at 60 °C to enhance autocatalytic cleavage. The transcripts
were purified on a denaturing polyacrylamide gel (12%
acrylamide:bisacrylamide (19:1), 8 M urea, 89 mM Tris borate, pH 8.3, 2 mM EDTA) and
electroeluted from the gel using a Schleicher & Schuell Biotrap. The
transcripts were extracted with phenol and chloroform, precipitated
with ethanol, resuspended in sterile water, and stored at
20 °C.
Cloning and Site-directed Mutagenesis of ProRSs--
ProS clones
of M. jannaschii, M. thermautotrophicus
(15), G. lamblia (21), and T. thermophilus HB8 (22) were described. A strain of
Novosphingobium aromaticivorans was obtained from M. F. Romine (Pacific Northwest National Laboratory, Richland, WA). Cells
were grown, and DNA was extracted by standard procedures. Chromosomal
R. palustris DNA was from C. S. Harwood (Iowa
University, Iowa City, IA), Cytophaga hutchinsonii DNA was
from M. J. McBride (University of Wisconsin-Milwaukee, Milwaukee,
WI), Borrelia burgdorferi DNA was from P. Rosa (National
Institutes of Health, Hamilton, MT), Clostridium sticklandii
DNA was from A. Pich (Universität Halle-Wittenberg, Germany)
(27), Magnetospirillum magnetotacticum DNA was from E. L. Bertani (California Institute of Technology, Pasadena, CA),
Deinococcus radiodurans DNA was from D. Tumbula-Hansen (Yale
University, New Haven, CT), and A. aeolicus DNA was from T. Steitz (Yale University, New Haven, CT).
The coding sequences of the proS genes were amplified by PCR
from genomic DNA and cloned into the pCR2.1 TOPO vector. Correct sequences were subsequently recloned into pET15b (Invitrogen) for
expression of the N-terminally His6-tagged protein in the E. coli BL21-Codon Plus (DE3)-RIL strain.
Deletions in the insertion sequence of the E. coli proS from
nucleotide (amino acid) positions 559-1128 (196-376) [ECdel1], 634-1182 (211-394) [ECdel2], 691-1050 (230-350) [ECdel3]
(see Fig. 1), and 652-1218 (217-406) [ECdel4] were prepared by
site-directed mutagenesis, and the genes were subcloned into pET20b for
expression of C-terminally His6-tagged proteins. The
resulting deletion genes encoded the extra 16 amino acids
(LKGEFCRTPSHWRPLE) originating from the TOPO vector on the C terminus
just before the His6-tag sequence. For comparison, the
E. coli wild-type proS gene was also cloned in
the same fashion. Deletion of nucleotides (amino acids) 691-1041 (230-347) of the A. aeolicus proS gene
[AAdel1], corresponding to the ECdel3 mutant of E. coli, was also made. The mutant gene was cloned into the
pET15b vector.
Overexpression and Purification of His6-tagged
Enzymes--
Cultures were grown at 37 °C in Luria-Bertani (LB)
medium supplemented with 100 µg/ml ampicillin and 34 µg/ml
chloramphenicol. Expression of the His6-tagged protein was
induced for 2-3 h at 30 °C with the addition of 1 mM
isopropyl-1-thio- -D-galactopyranoside before cell
harvesting. Expression of the ProRS deletion enzymes was induced with
0.2 mM isopropyl-1-thio- -D-galactopyranoside at 28 °C for 1 h.
The enzymes were purified by nickel-nitrilotriacetic acid
chromatography as described previously (22). The
His6-ProRSs were >95% pure as judged by Coomassie
Brilliant Blue staining after SDS-PAGE. Active fractions were pooled
and dialyzed against reaction buffer (50 mM HEPES-KOH, pH
7.2, 50 mM KCl, 15 mM MgCl2, 5 mM 2-mercaptoethanol, 1 mM benzamidine)
containing 40% glycerol and stored at 20 °C. The E. coli ProRS enzyme was further purified on DEAE-cellulose and Uno S
columns to minimize the possibility of E. coli
cysteinyl-tRNA synthetase contamination. For the DEAE-cellulose column,
50 mM Tris-HCl, pH 8.0, and a gradient of KCl (0-200
mM) were used. For the Uno S column, a gradient of
potassium phosphate (20-200 mM), pH 6.8, was used.
Active Site Titration--
Active site titration was performed
to determine the amount of active enzyme in the preparation. The
formation of ProRS·Pro-AMP complexes took place in 100 µl of
the 0.5× EAP buffer (50 mM Tris-HCl, pH 7.5, 5 mM KCl, 5 mM MgCl2) containing 0.5 units of inorganic pyrophosphatase and 20 µM
[14C]proline (500 cpm/pmol) in the presence of varying
concentrations of ProRSs (0.2-5 µM). After 1-10-min
incubation, aliquots of 30 µl were spotted onto nitrocellulose
filters, filtered, and washed twice with 5 ml of 0.5× EAP buffer. The
filters were dried, and the radioactivity was measured by liquid
scintillation counting.
ATP-PPi Exchange Assay--
The reaction mixture
(200 µl) contained 50 mM HEPES-NaOH, pH 7.2, 15 mM MgCl2, 50 mM KCl, 5 mM dithiothreitol, 1 mM potassium fluoride, 2 mM ATP, L-proline, or
L-cysteine varying from 5-500 µM for
Km determinations, 2 mM
[32P]pyrophosphate (2 cpm/pmol) and, when
indicated, 1 mg/ml of suitable unfractionated tRNA (E. coli
in the case of bacterial enzymes, M. jannaschii for archaeal
ProRs, and yeast for eukaryotic ProRSs). ProRS concentrations ranged
from 2-10 nM for proline activation and from 200-4000
nM for cysteine activation. After various incubation times,
the [32P]ATP present in 40-µl aliquots of the reaction
mixture was specifically adsorbed on acid-washed Norit (200 µl of a
1% suspension (w/v) of Norit in 0.4 M sodium pyrophosphate
solution containing 15% (v/v) perchloric acid) rinsed with 25 ml of
water and 10 ml of ethanol on Whatman GF/C fiberglass filter disks,
dried, and with the radioactivity determined by liquid scintillation
counting. Reactions were performed at 37 °C with the exception of
T. thermophilus, A. aeolicus, M. jannaschii, and M. thermautotrophicus ProRSs where the reaction temperature was
60 °C. Km and kcat values were determined using Hanes-Wolf plots.
Aminoacylation of tRNA--
The standard reaction mixture (100 µl) contained 50 mM HEPES-KOH, pH 7.2, 50 mM
KCl, 15 mM MgCl2, 5 mM
dithiothreitol, 10 mM ATP, 50 µM
[3H]proline (200 cpm/pmol) or 50 µM
[35S]cysteine (500 cpm/pmol), 1 mg/ml of suitable
unfractionated tRNA, and 1-10 nM purified recombinant
ProRSs for the proline charging or 40-2000 nM for
cysteine. Radioactive aminoacyl-tRNAs synthesized after 1-30 min were
quantified in 20-µl aliquots as described previously (15).
Assays for Post-transfer Editing--
Cys-tRNAPro
was generated by charging of unfractionated E. coli tRNA
with C. sticklandii ProRS. Mischarged E. coli
Ala-tRNAPro was generated by charging either the
E. coli tRNAPro transcript or
unfractionated E. coli tRNA with D. radiodurans ProRS. Charging reactions were performed in standard reaction buffer
using 50 µM [35S]cysteine or 500 µM [3H]alanine. After phenol and chloroform
extraction, the tRNA was precipitated with ethanol and the precipitate
was washed and dried. 0.5-2 µM of charged tRNA were used
in the 60-µl reaction. The deacylation assay was performed as
described previously (8). The reaction was initiated with 20 nM to 2 µM enzyme, and at each time point,
13-µl aliquots were removed. As a positive control, 0.1 M
NaOH was used instead of the enzyme. Reactions were quenched on Whatman
3MM filters pre-soaked with 10% trichloroacetic acid, washed, and
quantified as described for aminoacylation assays.
 |
RESULTS |
Selection of ProRS Enzymes for Study--
Because archaeal ProRS
enzymes charge cysteine in addition to proline onto tRNA (15), we
wanted to determine whether this property is widespread among this
family of enzymes. Therefore, we selected proS genes
from a number of organisms so that enzymes from all domains of life, as
well as from the two different structural classes, were represented.
The archaeal examples were M. jannaschii and M. thermautotrophicus, whereas Saccharomyces cerevisiae
represented the eukarya. We used a larger number of bacterial enzymes
as both archaeal-type and bacterial-type ProRS proteins are represented here. For the archaeal-type proS, T. thermophilus, D. radiodurans, C. sticklandii, N. aromaticivorans, C. hutchinsonii, B. burgdorferi, and M. magnetotacticum were selected, whereas the bacterial-type ProRS
was cloned from E. coli and the hyperthermophile
A. aeolicus. An atypical bacterial-type ProRS
lacking the insertion domain was cloned from R. palustris.
Because the insertion domain appears to be involved in editing (28), we
wanted to generate forms of the E. coli and A. aeolicus enzymes that lack partially or completely the 180-amino
acid insertion domain. Not unexpectedly, only two of the enzymes could
be expressed in a stable form. This was the ProRS ECdel3 enzyme
(see Fig. 1) with 452 amino acids compared with 572 amino acids in wild-type E. coli ProRS.
Similarly, the A. aeolicus ProRS AAdel1 lacked 117 amino
acids from the wild-type open reading frame of 570. In both of these
enzyme constructs, only 65% of the insertion domain was deleted;
however, they were significantly less stable than the wild-type
enzymes.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 1.
A schematic representation of the two ProRS
clusters. The shaded area in the insert illustrates the part that
was successfully deleted in the ECdel3 enzyme.
|
|
Cysteine Is a Substrate of ProRS--
Kinetic parameters of
cysteine and proline activation were determined by ATP-PPi
exchange (Table I). It is clear
that all of the ProRSs tested are able to use cysteine as substrate.
Cysteine activation (expressed as
kcat/Km) by these ProRSs was 30-1400-fold lower than the activation of the cognate proline. The
"affinities" of ProRSs for cysteine were surprisingly high (Km values ranging from 10-260 µM),
which was in most cases even higher than those for proline
(Km values ranging from 50-290 µM).
However, turnover numbers for cysteine activation were severely
decreased compared with proline (kcat dropped
150-2300-fold). Thus, cysteine activation is still considerably poorer
than proline activation. Alanine for comparison was also detectably
activated by ProRSs (20). It has a profoundly poorer affinity than
cysteine or proline (Km values between 31-500
mM); however the kcat values are
10-fold higher than those for cysteine (data not shown). Thus, cysteine
is still a significantly better substrate in ATP-PPi
exchange than alanine.
Although the addition of unfractionated tRNA significantly improved
cysteine activation in most cases, cysteine activation can always be
observed in the absence of tRNA (23, 29). tRNA-dependent cysteine activation is a property common to both archaeal-type and
bacterial-type ProRS families. The activation of cysteine by M. jannaschii ProRS, for instance, was found to be stimulated up to
4-fold in the presence of unfractionated tRNA, whereas a 2-fold
stimulation was observed for A. aeolicus ProRS (data not shown).
The ability of all ProRS enzymes to charge cysteine onto unfractionated
tRNA was tested by the standard aminoacylation assay and compared to
the reaction with proline. In this assay, the source of tRNA for most
ProRSs was E. coli. The archaeal enzymes were tested with
M. jannaschii tRNA and S. cerevisiae
ProRS with homologous tRNA. Most of the enzymes charged tRNA with
cysteine to a similar plateau level as with proline (data not shown).
The ratio of the initial velocities of proline versus
cysteine charging is plotted in Fig. 2.
As can be seen, the values greatly vary from 7 to 4900. The archaeal
enzymes and the closely related ProRS from the primitive eukaryote
G. lamblia showed the best cysteine charging, whereas the
eukaryotic S. cerevisiae enzyme showed the lowest. However,
even the bacterial-type A. aeolicus ProRS charges cysteine
very well. The effect of the insertion domain on cysteine charging was
investigated with the E. coli enzyme. The partial lack of
this domain in the bacterial-type ProRS ECdel3 showed a 2.3-fold
increase in the relative cysteine charging when compared with the
intact E. coli ProRS.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 2.
Ratio of initial rates of proline
acylation/cysteine acylation by various ProRSs. Enzymes from the
following organisms were used: AA, Aquifex aeolicus; BB,
Borrelia burgdorferi; CS, Clostridium
sticklandii; CH, Cytophaga hutchinsonii; DR,
Deinococcus radiodurans; EC, Escherichia coli;
ECdel3, Escherichia coli with partially deleted insert
region (see Text); GL, Giardia lamblia; MM,
Magnetospirillum magnetotacticum; MJ,
Methanocaldococcus jannaschii; MT, Methanothermobacter
thermautotrophicus; NA, Novosphingobium
aromaticivorans; RP, Rhodopseudomonas palustris; SC,
Saccharomyces cerevisiae; TT, Thermus
thermophilus. Bars representing E. coli wild-type and
deletion proteins are striped for easier comparison.
|
|
ProRS Forms Cys-tRNA Pro--
To determine tRNA
specificity of the ProRS enzymes, transcripts of E. coli
tRNAPro(CGG) or M. jannaschii
tRNAPro(UGG) (for the archaeal ProRSs), an E. coli tRNA preparation devoid of tRNACys (prepared
by benzoylated DEAE-cellulose chromatography), and EF1A-purified
E. coli tRNACys and T. thermophilus tRNACys were used. Because the results
with the different ProRS enzymes were essentially the same, only
the T. thermophilus ProRS acylation data are presented. The
tRNAPro transcript (Fig.
3A) or the tRNAPro
column fraction (Fig. 3B) was efficiently charged with both
proline and cysteine. This indicates that cysteine charging of
unfractionated tRNA is the result of Cys-tRNAPro formation.
In agreement with this finding, the pure E. coli
tRNACys and T. thermophilus
tRNACys preparations could not be cysteinylated by the
ProRS enzymes (Fig. 3B). Therefore, we conclude that
tRNAPro both as transcript and fully modified can be
readily mischarged with cysteine by all of the ProRSs tested.

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 3.
Proline and cysteine charging by
T. thermophilus ProRS. A,
charging of E. coli tRNAPro transcript (1.5 µM) with 50 µM proline and 50 nM enzyme ( ), or 50 µM cysteine and 750 nM enzyme ( ). B, partially purified mature
E. coli tRNA enriched in tRNAPro (2 µM) with 50 µM proline, and 50 nM enzyme ( ), or 50 µM cysteine, and 750 nM enzyme ( ); T. thermophilus
tRNACys (5 µM) with 50 µM
cysteine, and 750 nM enzyme ( ).
|
|
Post-transfer Editing by ProRS--
Because all of the ProRSs
tested misacylated tRNAPro, we examined their post-transfer
editing capacity using E. coli Cys-tRNAPro.
ProRSs from C. sticklandii, M. magnetotacticum, E. coli, A. aeolicus, and
R. palustris were tested, but even at high enzyme concentrations (1 µM), none showed any significant
deacylation of cysteine (Fig.
4A). Because E. coli ProRS is known to edit Ala-tRNAPro
(8, 28), we tested the alanine editing activity of our
ProRS enzymes. Only bacterial-type ProRS enzymes with the intact
insertion domain deacylate Ala-tRNAPro (Fig.
4B). Even the R. palustris ProRS, which has a
high similarity to the E. coli protein but lacks the
insertion domain, did not show any editing. As a further confirmation
to the reported involvement of the insertion domain in alanine editing
(28), we showed that the ProRS AAdel1 enzyme did not deacylate
Ala-tRNAPro (Fig. 4B).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 4.
Deacylation of mischarged E. coli
Cys-tRNAPro and
Ala-tRNAPro. A, deacylation of
Cys-tRNAPro with: 1 µM C. sticklandii ProRS ( ), 1 µM M. magnetotacticum ProRS ( ), 1 µM E. coli
ProRS ( ), 1 µM A. aeolicus ProRS ( ), 1 µM R. palustris ProRS ( ), 0.1 M
NaOH ( ), or no enzyme ( ). B, deacylation of
Ala-tRNAPro: 1 µM C. sticklandii
ProRS ( ), 1 µM M. magnetotacticum ProRS
( ), 40 nM E. coli ProRS ( ), 200 nM A. aeolicus ProRS ( ), 1 µM
R. palustris ProRS ( ), 200 nM AAdel1 ProRS
( ), or no enzyme ( ).
|
|
 |
DISCUSSION |
Mischarging of non-cognate amino acids by AARSs has been observed
previously (2). However, the levels of mischarging have been relatively
insignificant compared with the charging of the cognate amino acid, and
many AARSs are able to efficiently hydrolyze misactivated or mischarged
amino acids through their editing activities. The exceptions are mutant
AARSs that are unable to perform their editing function (7, 30-32). It
has been estimated that editing would be necessary for cell viability
if the discrimination factor between cognate and non-cognate amino
acids is <3000 (33). Wild-type ProRSs may present the only example
where lower discrimination factors naturally exist. ProRSs efficiently
misactivate cysteine and form Cys-tRNAPro, which appears
resistant to the editing functions of enzymes in vitro.
Although it is unclear whether archaeal-type ProRSs possess an editing
activity for Ala-tRNAPro (Ref. 20 and this study), the
bacterial-type enzymes certainly do (Refs. 8, 28, and this work).
Therefore, it is really puzzling why the bacterial-type ProRS does not
edit cysteine when it acts efficiently on alanine. This fact might be
explained if bacterial-type ProRSs were to use a double sieve mechanism
(3, 4), because the molecular volume of alanine is smaller than the
very similar volumes of proline and cysteine. As such, alanine would be
able to enter the active site of the enzyme where it could be
subsequently activated and even transferred onto tRNA. However, its
ability to be edited suggests that alanine fits also to the distinct
editing site, which was recently shown to be in the insertion domain of
bacterial-type ProRSs (Ref. 28 and this work). In contrast, having a
similar molecular volume to proline, cysteine cannot be edited without
putting at risk hydrolysis of the cognate amino acid. Hence, it seems
that cysteine evades efficient discrimination by both sieves so that
mischarging of cysteine remains the same problem for both the bacterial
and archaeal types of ProRS.
The highest rate of cysteine mischarging compared with that of the
cognate proline was shown by the archaeal ProRSs, where the high
cysteine acylation was initially observed (15). Looking at our
data, it appears that for most ProRSs, the rate of cysteine charging
correlates with that of activation. There probably is no significant
mechanism in place to prevent the transfer of activated cysteine onto
tRNA in vitro. However, S. cerevisiae,
C. sticklandii, and T. thermophilus ProRSs show
obviously poorer cysteine mischarging compared with the activation
data. This may be attributed to a better induced fit mechanism in these
enzymes. This mechanism, recently proposed for T. thermophilus ProRS (34), envisages the formation of
prolyl-adenylate as a prerequisite for a conformational change,
enabling correct binding of the 3' terminus of tRNA.
Although there are no data on the in vivo formation of
Cys-tRNAPro, it is difficult to imagine that the high level
of mischarging observed in vitro would be tolerated by
living cells. Careful regulation of intracellular proline and cysteine
levels of an organism or the presence of additional factors (protein or
RNA) may be required in vivo to prevent the formation of
Cys-tRNAPro or induce its hydrolysis. Yet, cysteine may
present a special challenge for fidelity in protein biosynthesis. An
analysis of the accuracy of charging of non-cognate amino acids by
seven yeast AARSs revealed poor specificity in discrimination of
cysteine by these enzymes (35). Furthermore, based on a number of
studies it was suggested that cysteine, possibly because of its small size and amphiphilic character, is an acceptable replacement at most
protein positions without deleterious effect on cell viability (32, 36,
37).
ProRS is the only aminoacyl-tRNA synthetase that charges two canonical
amino acids at similar levels without subsequent error correction. The
implications of this finding for AARS evolution are discussed below.
The co-evolution theory of the genetic code (38, 39) proposes cysteine
as a late addition to the amino acids used in encoded protein
synthesis. Furthermore, analysis of factors which might have
contributed to the temporal order of the amino acid recruitment in the
genetic code also proposed cysteine to have arrived late (40). Lastly,
a recent proteome analysis that potentially reveals how amino acid
frequencies in proteins evolved in biological time showed cysteine to
be a late addition to the protein amino acids (41). By the same
criteria proline is an `early' amino acid (38-41). To guarantee
efficiency in protein synthesis, aminoacyl-tRNA synthetases may have
evolved their particular specificities in response to the appearance of new amino acids. Thus, if cysteine was added to the pool of protein amino acids later than proline, an existing ProRS would not be expected
to have evolved means to discriminate against cysteine. In this
context, the difficulty of discriminating against the `newcomer'
amino acid cysteine is not surprising, especially if the new amino acid
has similar properties (molecular volume) to the cognate proline which
may make its editing mechanisms less efficient. Cysteinyl-tRNA
synthetase, on the other hand, arguably a much newer enzyme that did
not yet reach some methanogens (17, 18, 42), evolved as a highly
discriminating enzyme employing a metal ion (Zn2+) for
specific cysteine recognition (43) and not requiring editing (44). This
leaves unresolved the question as to why ProRS did not subsequently
evolve a means to discriminate against cysteine; the misreading of
proline codons as cysteine would surely have provided a powerful
selective pressure. This may readily be explained by the observation
that the accuracy of ProRS product formation may be more dependent on
intracellular amino acid levels than that of any other aminoacyl-tRNA
synthetase, providing a highly effective example of kinetic discrimination.
 |
ACKNOWLEDGEMENTS |
We thank M. Ibba, S. Bunjun-Srihari, and B. Ruan for many discussions. We are grateful to Drs. E. L. Bertani,
C. S. Harwood, M. McBride, A. Pich, M. Romine, P. Rosa, T. Steitz,
and D. Tumbula-Hansen for gifts of strains, DNA, and enzymes.
 |
FOOTNOTES |
*
This work was supported by grants from the NIGMS, National
Institutes of Health, the Department of Energy, and the National Aeronautics and Space Administration.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
Present address: Integrated Genomics, Winzlauer Strasse 2a,
D-07745 Jena, Germany.
To whom correspondence should be addressed: Dept. of Molecular
Biophysics and Biochemistry, Yale University, P. O. Box 208114, 266 Whitney Ave., New Haven, CT 06520-8114. Tel.: 203-432-6200; Fax:
203-432-6202; E-mail: soll@trna.chem.yale.edu.
Published, JBC Papers in Press, July 18, 2002, DOI 10.1074/jbc.M206928200
 |
ABBREVIATIONS |
The abbreviations used are:
AARS, aminoacyl-tRNA
synthetase;
ProRS, prolyl-tRNA synthetase;
MOPS, 4-morpholinepropanesulfonic acid;
ATP-PPi, ATP-pyrophosphate.
 |
REFERENCES |
| 1.
|
Ibba, M.,
and Söll, D.
(2000)
Annu. Rev. Biochem.
69,
617-650[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Jakubowski, H.,
and Goldman, E.
(1992)
Microbiol. Rev.
56,
412-429[Abstract/Free Full Text]
|
| 3.
|
Fersht, A. R.,
and Dingwall, C.
(1979)
Biochemistry
18,
2627-2631[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Fersht, A. R.
(1998)
Science
280,
541[Free Full Text]
|
| 5.
|
Jakubowski, H.,
and Fersht, A. R.
(1981)
Nucleic Acids Res.
9,
3105-3117[Abstract/Free Full Text]
|
| 6.
|
Nureki, O.,
Vassylyev, D. G.,
Tateno, M.,
Shimada, A.,
Nakama, T.,
Fukai, S.,
Konno, M.,
Hendrickson, T. L.,
Schimmel, P.,
and Yokoyama, S.
(1998)
Science
280,
578-582[Abstract/Free Full Text]
|
| 7.
|
Dock-Bregeon, A.,
Sankaranarayanan, R.,
Romby, P.,
Caillet, J.,
Springer, M.,
Rees, B.,
Francklyn, C. S.,
Ehresmann, C.,
and Moras, D.
(2000)
Cell
103,
877-884[CrossRef][Medline]
[Order article via Infotrieve]
|
| 8.
|
Beuning, P. J.,
and Musier-Forsyth, K.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
8916-8920[Abstract/Free Full Text]
|
| 9.
|
Woese, C. R.,
Olsen, G.,
Ibba, M.,
and Söll, D.
(2000)
Microbiol. Mol. Biol. Rev.
64,
202-236[Abstract/Free Full Text]
|
| 10.
|
Ribas de Pouplana, L.,
Brown, J. R.,
and Schimmel, P.
(2001)
J. Mol. Evol.
53,
261-268[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Yaremchuk, A.,
Cusack, S.,
and Tukalo, M.
(2000)
EMBO J.
19,
4745-4758[CrossRef][Medline]
[Order article via Infotrieve]
|
| 12.
|
Burke, B.,
Lipman, R. S.,
Shiba, K.,
Musier-Forsyth, K.,
and Hou, Y. M.
(2001)
J. Biol. Chem.
276,
20286-20291[Abstract/Free Full Text]
|
| 13.
|
Lee, M. L.,
and Muench, K. H.
(1969)
J. Biol. Chem.
244,
223-230[Abstract/Free Full Text]
|
| 14.
|
Rivera, J. A.,
Wang, Q. S.,
and Wong, J. T.
(1984)
Can. J. Biochem. Cell Biol.
62,
507-515[Medline]
[Order article via Infotrieve]
|
| 15.
|
Stathopoulos, C., Li, T.,
Longman, R.,
Vothknecht, U. C.,
Becker, H. D.,
Ibba, M.,
and Söll, D.
(2000)
Science
287,
479-482[Abstract/Free Full Text]
|
| 16.
|
Lipman, R. S. A.,
Sowers, K. R.,
and Hou, Y. M.
(2000)
Biochemistry
39,
7792-7798[CrossRef][Medline]
[Order article via Infotrieve]
|
| 17.
|
Bult, C. J.,
White, O.,
Olsen, G. J.,
Zhou, L.,
Fleischmann, R. D.,
Sutton, G. G.,
Blake, J. A.,
FitzGerald, L. M.,
Clayton, R. A.,
Gocayne, J. D.,
Kerlavage, A. R.,
Dougherty, B. A.,
Tomb, J. F.,
Adams, M. D.,
Reich, C. I.,
Overbeek, R.,
Kirkness, E. F.,
Weinstock, K. G.,
Merrick, J. M.,
Glodek, A.,
Scott, J. L.,
Geoghagen, N. S. M.,
and Venter, J. C.
(1996)
Science
273,
1058-1073[Abstract]
|
| 18.
|
Smith, D. R.,
Doucette-Stamm, L. A.,
Deloughery, C.,
Lee, H.,
Dubois, J.,
Aldredge, T.,
Bashirzadeh, R.,
Blakely, D.,
Cook, R.,
Gilbert, K.,
Harrison, D.,
Hoang, L.,
Keagle, P.,
Lumm, W.,
Pothier, B.,
Qiu, D.,
Spadafora, R.,
Vicaire, R.,
Wang, Y.,
Wierzbowski, J.,
Gibson, R.,
Jiwani, N.,
Caruso, A.,
Bush, D.,
and Reeve, J. N.
(1997)
J. Bacteriol.
179,
7135-7155[Abstract/Free Full Text]
|
| 19.
|
Stathopoulos, C.,
Jacquin-Becker, C.,
Becker, H. D., Li, T.,
Ambrogelly, A.,
Longman, R.,
and Söll, D.
(2001)
Biochemistry
40,
46-52[CrossRef][Medline]
[Order article via Infotrieve]
|
| 20.
|
Beuning, P. J.,
and Musier-Forsyth, K.
(2001)
J. Biol. Chem.
276,
30779-30785[Abstract/Free Full Text]
|
| 21.
|
Bunjun, S.,
Stathopoulos, C.,
Graham, D.,
Min, B.,
Kitabatake, M.,
Wang, A. L.,
Wang, C. C.,
Vivares, C. P.,
Weiss, L. M.,
and Söll, D.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
97,
12997-13002[Abstract/Free Full Text]
|
| 22.
|
Feng, L.,
Stathopoulos, C.,
Ahel, I.,
Mitra, A.,
Tumbula-Hansen, D.,
Hartsch, T.,
and Söll, D.
(2002)
Extremophiles
6,
167-174[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Jacquin-Becker, C.,
Ahel, I.,
Ambrogelly, A.,
Ruan, B.,
Söll, D.,
and Stathopoulos, C.
(2002)
FEBS Lett.
514,
34-36[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Curnow, A. W.,
Tumbula, D. L.,
Pelaschier, J. T.,
Min, B.,
and Söll, D.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
12838-12843[Abstract/Free Full Text]
|
| 25.
|
Gillam, I.,
Millward, D. B.,
von Tigerstrom, M.,
Wimmer, E.,
and Tener, G. M.
(1967)
Biochemistry
6,
3043-3056[CrossRef][Medline]
[Order article via Infotrieve]
|
| 26.
|
Fechter, P.,
Rudinger, J.,
Giegé, R.,
and Théobald-Dietrich, A.
(1998)
FEBS Lett.
436,
99-103[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Kabisch, U. C.,
Grantzdorffer, A.,
Schierhorn, A.,
Rucknagel, K. P.,
Andreesen, J. R.,
and Pich, A.
(1999)
J. Biol. Chem.
274,
8445-8454[Abstract/Free Full Text]
|
| 28.
|
Wong, F. C.,
Beuning, P. J.,
Nagan, M.,
Shiba, K.,
and Musier-Forsyth, K.
(2002)
Biochemistry
41,
7108-7115[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Lipman, R. S. A.,
Beuning, P. J.,
Musier-Forsyth, K.,
and Hou, Y. M.
(2002)
J. Mol. Biol.
316,
421-427[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Chen, J. F.,
Guo, N. N., Li, T.,
Wang, E. D.,
and Wang, Y. L.
(2000)
Biochemistry
39,
6726-6731[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Mursinna, R. S.,
and Martinis, S. A.
(2002)
J. Am. Chem. Soc.
124,
7286-7287[CrossRef][Medline]
[Order article via Infotrieve]
|
| 32.
|
Döring, V.,
Mootz, H. D.,
Nangle, L. A.,
Hendrickson, T. L.,
de Crecy-Lagard, V.,
Schimmel, P.,
and Marlière, P.
(2001)
Science
292,
501-504[Abstract/Free Full Text]
|
| 33.
|
Fersht, A. R.
(1981)
Proc. R. Soc. Lond. B Biol. Sci.
212,
351-379[Medline]
[Order article via Infotrieve]
|
| 34.
|
Yaremchuk, A.,
Tukalo, M.,
Grøtli, M.,
and Cusack, S.
(2001)
J. Mol. Biol.
309,
989-1002[CrossRef][Medline]
[Order article via Infotrieve]
|
| 35.
|
Freist, W.,
Sternbach, H.,
Pardowitz, I.,
and Cramer, F.
(1998)
J. Theor. Biol.
193,
19-38[CrossRef][Medline]
[Order article via Infotrieve]
|
| 36.
|
Döring, V.,
and Marlière, P.
(1998)
Genetics
150,
543-551[Abstract/Free Full Text]
|
| 37.
|
Edelmann, P.,
and Gallant, J.
(1977)
Cell
10,
131-137[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Wong, J. T.
(1975)
Proc. Natl. Acad. Sci. U. S. A.
72,
1909-1912[Abstract/Free Full Text]
|
| 39.
|
Di Giulio, M.,
and Medugno, M.
(1999)
J. Mol. Evol.
49,
1-10[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Trifonov, E. N.
(2000)
Gene (Amst.)
261,
139-151[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Brooks, D. J.,
and Fresco, J. R.
(2002)
Mol. Cell. Proteomics
1,
125-131[Abstract/Free Full Text]
|
| 42.
|
Slesarev, A. I.,
Mezhevaya, K. V.,
Makarova, K. S.,
Polushin, N. N.,
Shcherbinina, O. V.,
Shakhova, V. V.,
Belova, G. I.,
Aravind, L.,
Natale, D. A.,
Rogozin, I. B.,
Tatusov, R. L.,
Wolf, Y. I.,
Stetter, K. O.,
Malykh, A. G.,
Koonin, E. V.,
and Kozyavkin, S. A.
(2002)
Proc. Natl. Acad. Sci. U. S. A.
99,
4644-4649[Abstract/Free Full Text]
|
| 43.
|
Newberry, K. J.,
Hou, Y. M.,
and Perona, J. J.
(2002)
EMBO J.
21,
2778-2787[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Fersht, A. R.,
and Dingwall, C.
(1979)
Biochemistry
18,
1245-1249[CrossRef][Medline]
[Order article via Infotrieve]
|
| 45.
|
Ambrogelly, A.,
Ahel, I.,
Polycarpo, C.,
Bunjun-Srihari, S.,
Krett, B.,
Jacquin-Becker, C.,
Ruan, B.,
Köhrer, C.,
Stathopoulos, C.,
RajBhandary, U. L.,
and Söll, D.
(2002)
J. Biol. Chem.
277,
34749-34754[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
B. Ruan, S. Palioura, J. Sabina, L. Marvin-Guy, S. Kochhar, R. A. LaRossa, and D. Soll
Quality control despite mistranslation caused by an ambiguous genetic code
PNAS,
October 28, 2008;
105(43):
16502 - 16507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L.-T. Guo, X.-L. Chen, B.-T. Zhao, Y. Shi, W. Li, H. Xue, and Y.-X. Jin
Human tryptophanyl-tRNA synthetase is switched to a tRNA-dependent mode for tryptophan activation by mutations at V85 and I311
Nucleic Acids Res.,
September 27, 2007;
35(17):
5934 - 5943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. SternJohn, S. Hati, P. G. Siliciano, and K. Musier-Forsyth
Restoring species-specific posttransfer editing activity to a synthetase with a defunct editing domain
PNAS,
February 13, 2007;
104(7):
2127 - 2132.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Metlitskaya, T. Kazakov, A. Kommer, O. Pavlova, M. Praetorius-Ibba, M. Ibba, I. Krasheninnikov, V. Kolb, I. Khmel, and K. Severinov
Aspartyl-tRNA Synthetase Is the Target of Peptide Nucleotide Antibiotic Microcin C
J. Biol. Chem.,
June 30, 2006;
281(26):
18033 - 18042.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. An and K. Musier-Forsyth
Cys-tRNAPro Editing by Haemophilus influenzae YbaK via a Novel Synthetase{middle dot}YbaK{middle dot}tRNA Ternary Complex
J. Biol. Chem.,
October 14, 2005;
280(41):
34465 - 34472.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ruan and D. Soll
The Bacterial YbaK Protein Is a Cys-tRNAPro and Cys-tRNACys Deacylase
J. Biol. Chem.,
July 8, 2005;
280(27):
25887 - 25891.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rinehart, B. Krett, M. A. T. Rubio, J. D. Alfonzo, and D. Soll
Saccharomyces cerevisiae imports the cytosolic pathway for Gln-tRNA synthesis into the mitochondrion
Genes & Dev.,
March 1, 2005;
19(5):
583 - 592.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ruan, M. L. Bovee, M. Sacher, C. Stathopoulos, K. Poralla, C. S. Francklyn, and D. Soll
A Unique Hydrophobic Cluster Near the Active Site Contributes to Differences in Borrelidin Inhibition among Threonyl-tRNA Synthetases
J. Biol. Chem.,
January 7, 2005;
280(1):
571 - 577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Korencic, C. Polycarpo, I. Weygand-Durasevic, and D. Soll
Differential Modes of Transfer RNASer Recognition in Methanosarcina barkeri
J. Biol. Chem.,
November 19, 2004;
279(47):
48780 - 48786.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. An and K. Musier-Forsyth
Trans-editing of Cys-tRNAPro by Haemophilus influenzae YbaK Protein
J. Biol. Chem.,
October 8, 2004;
279(41):
42359 - 42362.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Korencic, I. Ahel, J. Schelert, M. Sacher, B. Ruan, C. Stathopoulos, P. Blum, M. Ibba, and D. Soll
A freestanding proofreading domain is required for protein synthesis quality control in Archaea
PNAS,
July 13, 2004;
101(28):
10260 - 10265.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Rinehart, E. K. Horn, D. Wei, D. Soll, and A. Schneider
Non-canonical Eukaryotic Glutaminyl- and Glutamyl-tRNA Synthetases Form Mitochondrial Aminoacyl-tRNA in Trypanosoma brucei
J. Biol. Chem.,
January 9, 2004;
279(2):
1161 - 1166.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Ruan, H. Nakano, M. Tanaka, J. A. Mills, J. A. DeVito, B. Min, K. B. Low, J. R. Battista, and D. Soll
Cysteinyl-tRNACys Formation in Methanocaldococcus jannaschii: the Mechanism Is Still Unknown
J. Bacteriol.,
January 1, 2004;
186(1):
8 - 14.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
F.-C. Wong, P. J. Beuning, C. Silvers, and K. Musier-Forsyth
An Isolated Class II Aminoacyl-tRNA Synthetase Insertion Domain Is Functional in Amino Acid Editing
J. Biol. Chem.,
December 26, 2003;
278(52):
52857 - 52864.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Ahel, D. Korencic, M. Ibba, and D. Soll
Trans-editing of mischarged tRNAs
PNAS,
December 23, 2003;
100(26):
15422 - 15427.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. O'Donoghue and Z. Luthey-Schulten
On the Evolution of Structure in Aminoacyl-tRNA Synthetases
Microbiol. Mol. Biol. Rev.,
December 1, 2003;
67(4):
550 - 573.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. Waters, M. J. Hohn, I. Ahel, D. E. Graham, M. D. Adams, M. Barnstead, K. Y. Beeson, L. Bibbs, R. Bolanos, M. Keller, et al.
The genome of Nanoarchaeum equitans: Insights into early archaeal evolution and derived parasitism
PNAS,
October 28, 2003;
100(22):
12984 - 12988.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Kamtekar, W. D. Kennedy, J. Wang, C. Stathopoulos, D. Soll, and T. A. Steitz
The structural basis of cysteine aminoacylation of tRNAPro by prolyl-tRNA synthetases
PNAS,
February 18, 2003;
100(4):
1673 - 1678.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. D. Buechter, D. N. Paolella, B. S. Leslie, M. S. Brown, K. A. Mehos, and E. A. Gruskin
Co-translational Incorporation of Trans-4-Hydroxyproline into Recombinant Proteins in Bacteria
J. Biol. Chem.,
January 3, 2003;
278(1):
645 - 650.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Ambrogelly, I. Ahel, C. Polycarpo, S. Bunjun-Srihari, B. Krett, C. Jacquin-Becker, B. Ruan, C. Kohrer, C. Stathopoulos, U. L. RajBhandary, et al.
Methanocaldococcus jannaschii Prolyl-tRNA Synthetase Charges tRNAPro with Cysteine
J. Biol. Chem.,
September 13, 2002;
277(38):
34749 - 34754.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|